Bank Of America Corp Editas Medicine, Inc. Transaction History

Bank Of America Corp

  • $1.33 Trillion
  • Q2 2025

A detailed history of Bank Of America Corp transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,079,696 shares of EDIT stock, worth $2.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,079,696
Previous 1,517,655 28.86%
Holding current value
$2.88 Million
Previous $1.76 Million 34.94%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$0.98 - $2.35 $429,199 - $1.03 Million
-437,959 Reduced 28.86%
1,079,696 $2.38 Million
Q1 2025

May 15, 2025
BUY
$1.14 - $3.2 $1.24 Million - $3.47 Million
1,084,483 Added 250.36%
1,517,655 $1.76 Million
Q4 2024

Feb 14, 2025
SELL
$1.2 - $3.76 $538,880 - $1.69 Million
-449,067 Reduced 50.9%
433,172 $550,000
Q3 2024

Nov 14, 2024
BUY
$3.39 - $5.96 $1.16 Million - $2.04 Million
342,513 Added 63.46%
882,239 $3.01 Million
Q2 2024

Aug 14, 2024
SELL
$4.67 - $7.28 $1.67 Million - $2.6 Million
-356,921 Reduced 39.81%
539,726 $2.52 Million
Q1 2024

May 15, 2024
BUY
$7.03 - $11.07 $3.69 Million - $5.81 Million
524,563 Added 140.98%
896,647 $6.65 Million
Q4 2023

Feb 14, 2024
SELL
$6.25 - $11.11 $350,306 - $622,704
-56,049 Reduced 13.09%
372,084 $3.77 Million
Q2 2023

Aug 14, 2023
SELL
$6.36 - $11.47 $3.27 Million - $5.89 Million
-513,762 Reduced 54.55%
428,133 $3.52 Million
Q1 2023

May 12, 2023
BUY
$7.03 - $11.53 $567,531 - $930,816
80,730 Added 9.37%
941,895 $6.83 Million
Q4 2022

Feb 10, 2023
BUY
$8.32 - $13.21 $3.35 Million - $5.32 Million
402,363 Added 87.7%
861,165 $7.64 Million
Q3 2022

Nov 14, 2022
BUY
$12.16 - $19.42 $1.99 Million - $3.18 Million
163,966 Added 55.61%
458,802 $5.62 Million
Q2 2022

Aug 12, 2022
SELL
$9.99 - $21.35 $101,828 - $217,620
-10,193 Reduced 3.34%
294,836 $3.49 Million
Q1 2022

May 16, 2022
BUY
$14.08 - $27.63 $451,742 - $886,480
32,084 Added 11.75%
305,029 $5.8 Million
Q4 2021

Feb 08, 2022
SELL
$26.55 - $40.57 $796,048 - $1.22 Million
-29,983 Reduced 9.9%
272,945 $7.25 Million
Q3 2021

Nov 15, 2021
BUY
$39.27 - $72.94 $2.39 Million - $4.43 Million
60,802 Added 25.11%
302,928 $12.4 Million
Q2 2021

Sep 13, 2021
BUY
$31.29 - $56.64 $7.58 Million - $13.7 Million
242,126 New
242,126 $13.7 Million

Others Institutions Holding EDIT

# of Institutions
218
Shares Held
45.5M
Call Options Held
476K
Put Options Held
338K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $184M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email